Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection


Venkatesan S., Myles P. R. , Bolton K. J. , Muthuri S. G. , Al Khuwaitir T., Anovadiya A. P. , ...More

JOURNAL OF INFECTIOUS DISEASES, vol.221, no.3, pp.356-366, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 221 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.1093/infdis/jiz152
  • Title of Journal : JOURNAL OF INFECTIOUS DISEASES
  • Page Numbers: pp.356-366
  • Keywords: Neuraminidase inhibitors, pandemic influenza, IPD meta-analysis, length of stay, antivirals, OSELTAMIVIR TREATMENT, CLINICAL-FEATURES, CHILDREN, OUTCOMES, ADULTS, COMPLICATIONS, RESISTANCE, IMPACT, COHORT, RISK

Abstract

Background. The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.